LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Search

Penumbra Inc

Fechado

SetorSaúde

320.7 0.4

Visão Geral

Variação de preço das ações

24h

Atual

Mín

319.37

Máximo

321.56

Indicadores-chave

By Trading Economics

Rendimento

163M

33M

Vendas

-11M

375M

P/E

Médio do Setor

73.491

49.888

EPS

0.82

Margem de lucro

8.695

Funcionários

4,700

EBITDA

-30M

38M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+12.17% upside

Dividendos

By Dow Jones

Próximos Ganhos

28 de jul. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-224M

13B

Abertura anterior

320.3

Fecho anterior

320.7

Sentimento de Notícias

By Acuity

50%

50%

154 / 344 Ranking em Healthcare

Penumbra Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

15 de jan. de 2026, 13:29 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock -- 2nd Update

15 de jan. de 2026, 12:35 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock -- Update

15 de jan. de 2026, 12:29 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock

6 de mai. de 2026, 20:15 UTC

Ganhos

Penumbra Not Be Providing Fincl Guidance Due to Pending Acquisition by Boston Scientific >PEN

6 de mai. de 2026, 20:07 UTC

Ganhos

Penumbra 1Q Rev $374.8M >PEN

6 de mai. de 2026, 20:07 UTC

Ganhos

Penumbra 1Q EPS 82c >PEN

25 de fev. de 2026, 18:02 UTC

Ganhos

Penumbra: Won't Be Providing Financial Guidance for 2026, Citing Proposed Boston Scientific Deal

25 de fev. de 2026, 18:01 UTC

Ganhos

Penumbra 4Q Rev $385.4M >PEN

25 de fev. de 2026, 18:01 UTC

Ganhos

Penumbra 4Q Adj EPS $1.18 >PEN

25 de fev. de 2026, 18:01 UTC

Ganhos

Penumbra 4Q EPS $1.20 >PEN

24 de jan. de 2026, 06:18 UTC

Aquisições, Fusões, Aquisições de Empresas

Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. -- Barrons.com

15 de jan. de 2026, 14:37 UTC

Ações em Alta

Stocks to Watch Thursday: Goldman Sachs, Boston Scientific, BlackRock -- WSJ

15 de jan. de 2026, 13:45 UTC

Aquisições, Fusões, Aquisições de Empresas

Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion. -- Barrons.com

15 de jan. de 2026, 12:04 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific: Penumbra Shareholders Can Elect to Receive Cash or Stock >BSX PEN

15 de jan. de 2026, 12:03 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific: Acquisition to Expand Cardiovascular Portfolio >BSX PEN

15 de jan. de 2026, 12:01 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific: Penumbra Deal Carriers an Enterprise Value of About $14.5 Billion >BSX

15 de jan. de 2026, 12:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific to Buy Penumbra for $374/Share >BSX PEN

15 de jan. de 2026, 12:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific Announces Agreement To Acquire Penumbra, Inc. >BSX PEN

Comparação entre Pares

Variação de preço

Penumbra Inc Previsão

Preço-alvo

By TipRanks

12.17% parte superior

Previsão para 12 meses

Média 358.25 USD  12.17%

Máximo 374 USD

Mínimo 335 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Penumbra Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

4 ratings

1

Comprar

3

Manter

0

Vender

Sentimento

By Acuity

154 / 344 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
help-icon Live chat